Hailed as a major step forward in the effort to develop targeted cancer therapies, a recently approved drug for the most common type of skin cancer has been a mixed blessing for patients. Although the initial response is usually dramatic, the tumors often recur as the cancer becomes resistant to treatment. Now researchers at the Stanford University School of Medicine have identified a second way to block the activity of the signaling cascade, called the Hedgehog pathway, that is abnormally active in these cancers... via Health News from Medical News Today Read More Here..
Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2013/03/study-offers-hope-in-fight-against.html
No comments:
Post a Comment